Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05357612 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Characterization of the Serotonin 2A Receptor Selective PET Tracer [18F]MH.MZ in Patients With Neurodegenerative Diseases

StatusRecruiting
PhasePhase 4
Started2023-01-23
View on ClinicalTrials.gov ↗

Amendment history

2026-08-04
minor
Study Status, Sponsor/Collaborators v8
Re-verified, no change to tracked fields
2026-07-16
minor
Study Status, Oversight v7
Primary completion date2026-06→2027-06
Completion date2026-08→2027-08
2025-08-06
minor
Study Status, Contacts/Locations v6
Primary completion date2025-06→2026-06
Completion date2025-08→2026-08
Study sitescontacts updated at 1 of 1 site
2025-04-04
minor
Study Status, Oversight v5
Re-verified, no change to tracked fields
2024-02-27
minor
Study Status v4
Primary completion date2024-06→2025-06
Completion date2024-08→2025-08
Show 3 earlier versions
2023-02-14
minor
Study Status v3
Re-verified, no change to tracked fields
2023-01-24
notable
Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v2
Trial statusNot Yet Recruiting→Recruiting
Start date2022-11→2023-01-23
Study sites0→1
2022-08-12
minor
Study Status v1
Start date2022-06→2022-11
2022-04-26
minor
Original filing
It is hypothesize that patients with clinically diagnosed neurodegenerative diseases will have significantly different receptor occupancy of 5HT2A receptors compared to a healthy age/sex-matched control group. This will be tested by measuring 5HT2A receptor density using the PET radioligand (R)-\[18F\]MH.MZ in both populations.
Trial Details
NCT Number NCT05357612
Lead Sponsor Vanderbilt University Medical Center
Collaborators: ACADIA Pharmaceuticals Inc.
Conditions Neurodegenerative Diseases, Parkinson Disease, Parkinson Disease Psychosis
Enrollment 75 participants
Start Date 2023-01-23
Primary Completion 2027-06 (estimated)
Study Completion 2027-08 (estimated)
Updated on ClinicalTrials.gov 2026-08-07